SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

07 Nov 2023 Evaluate
Revenue showed a marginal decline at Rs. 21593.00 millions. For the quarter ended September 2023, as compared to corresponding quarter of last year.Profit for the quarter ended September 2023 rises by 78.45% to Rs. 8050.00  millions from Rs. 4511.00 millions.Operating Profit saw a handsome growth to 11839.00 millions from 7882.00 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 21593.00 22618.00 -4.53 51150.00 41393.00 23.57 87316.00 78369.00 11.42
Other Income 6212.00 2462.00 152.32 7036.00 4013.00 75.33 5484.00 1787.00 206.88
PBIDT 11839.00 7882.00 50.20 24073.00 13842.00 73.91 30028.00 20968.00 43.21
Interest 909.00 641.00 41.81 1806.00 1047.00 72.49 2782.00 1349.00 106.23
PBDT 10930.00 7241.00 50.95 22267.00 12795.00 74.03 25208.00 16426.00 53.46
Depreciation 1249.00 1240.00 0.73 2461.00 2471.00 -0.40 4886.00 4787.00 2.07
PBT 9681.00 6001.00 61.32 19806.00 10324.00 91.84 20322.00 11639.00 74.60
TAX 1631.00 1490.00 9.46 3947.00 2498.00 58.01 5030.00 3060.00 64.38
Deferred Tax -85.00 44.00 -293.18 -133.00 38.00 -450.00 412.00 458.00 -10.04
PAT 8050.00 4511.00 78.45 15859.00 7826.00 102.65 15292.00 8579.00 78.25
Equity 1012.00 1012.00 0.00 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 54.83 34.85 57.33 47.06 33.44 40.74 34.39 26.76 28.53

Zydus Lifesciences Share Price

942.55 3.35 (0.36%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×